In January 2006, the U.S. Food and Drug Administration (FDA) approved a new antianginal agent for the treatment of chronic stable angina, ranolazine (Ranexa™; CV Therapeutics, Inc.). The drug, ...

Background: Chronic angina carries an economicburden because of symptom management, the riskof major cardiovascular events, and lost productivity.The level of these costs has not been ...

Chronic coronary disease, previously known as stable ischemic heart disease, is a spectrum of coronary artery disease characterized by obstructive or nonobstructive atherosclerotic plaque accumulation ...

Complete revascularization with PCI results in better health status for patients with multivessel, stable CAD than either incomplete revascularization or a conservative strategy of guideline-directed ...

Are there clinical advantages to augmenting standard therapy for stable ischemic heart disease with an angiotensin-converting enzyme (ACE) inhibitor or angiotensin receptor blocker (ARB)? Adding an ...

Folks suffering chest pain from clogged arteries appear to have some true flexibility in choosing the medical care that's right for them, researchers report. That's because their overall risk of death ...

Isomab Ltd ("Isomab") a UK-based biotechnology company developing novel therapies to restore vascularization in ...

Please provide your email address to receive an email when new articles are posted on . The study included data on 32,691 patients with stable CAD from the prospective, observational CLARIFY registry.

Angina pectoris, characterised by transient chest pain resulting from myocardial ischaemia, remains a leading symptom in coronary heart disease. Conventional management focuses on pharmacological ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Among stable outpatients with CAD, 21.2% reported ...

SUNNYVALE, Calif., Sept. 18, 2025 (GLOBE NEWSWIRE) -- BioCardia, Inc. (NASDAQ: BCDA), a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, ...

Most patients with coronary artery disease (CAD) and chronic stable angina will obtain complete relief of symptoms with percutaneous coronary intervention (PCI). However, some chronic angina patients ...